The Academy of Managed Care Pharmacy (AMCP) appreciates the opportunity to comment on Sub. H.B. No. 505 regarding the regulation of biological products and the substitution of interchangeable biological products when dispensed by pharmacists. AMCP is opposed to this legislation as it places an undue burden on the dispensing of interchangeable biological products once approved by the FDA.
We, the undersigned organizations representing a research and policy organization, healthcare plan sponsors, managed care pharmacists, and pharmacy benefit managers, urge conferees to include a provision in the final legislation that would authorize the use of patient review and restriction (PRR) programs by Medicare plan sponsors.
The Academy of Managed Care Pharmacy (AMCP) is writing to express our concerns with House Bill 791 – an act mandating that health plans and other health insurers follow a government mandated Step Therapy Exception Determination process.
The Academy of Managed Care Pharmacy (AMCP) supports the use of abuse deterrent opioid analgesic drug products; however, we are opposed to House Bill 2743 because it mandates coverage for these drug products, mandates preferred drug coverage status on formularies and sets arbitrary limits on copayments, deductibles or coinsurance that may result in increased costs to patients and public and private payers.
The Academy of Managed Care Pharmacy (AMCP) urges you to veto House Bill 1608 which would require the Insurance Commissioner to develop multiple prior authorization forms. For years, paper forms were used for prior authorization; however since 2013, an electronic standard for electronic prior authorization (ePA) has been available.
AMCP is writing to express our serious concerns regarding the inclusion of Section 11, Biological Product Innovation in the FDA and NIH Workforce Authorities Modernization Act (S. 2700)— part of the Senate Innovations legislation marked up in the HELP Committee.
Press Release: Interpretation of biomedical statistics and principles of evidence-based medicine are the top two general curriculum subjects that best prepare student pharmacists for the Academy of Managed Care Pharmacy (AMCP) Foundation Annual Pharmacy & Therapeutics (P&T) Competition.